Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Rossmax International Ltd. (4121:TWSE), powered by AI.
Rossmax International Ltd. is currently trading at $13.65. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Rossmax International Ltd. on Alpha Lenz.
View Rossmax International Ltd.'s valuation metrics on Alpha Lenz.
“Rossmax International Ltd.'s ROE is -2.1%. Explore profitability and growth together.”
Ask for details →Rossmax International Ltd. is a healthcare equipment manufacturer based in Taipei, Taiwan, specializing in the design, production, and global distribution of medical devices. The company’s core activities span the fields of prevention, monitoring, and therapy, offering a comprehensive range of products including blood pressure monitors, digital thermometers, nebulizers, personal scales for fitness and obesity management, and advanced solutions for respiratory care, fever management, and pain therapy. Rossmax International is recognized for its technological innovation, holding numerous patents, and for being among the first outside Japan to manufacture wrist blood pressure monitors with dual-user memory functions. The company’s commitment to clinical validation and quality standards is reflected in its certifications such as FDA and CE Mark. Serving healthcare providers and consumers in over 90 countries, Rossmax plays a significant role in advancing home and clinical health diagnostics, supporting the growing global emphasis on preventive healthcare and chronic disease management. With its fully integrated manufacturing facilities and continuous research and development, Rossmax International is a notable player in the medical equipment and healthcare technology sectors.
“Rossmax International Ltd.'s ROE is -2.1%. Explore profitability and growth together.”
Ask for details →Rossmax International Ltd. (ticker: 4121) is a company listed on TWSE in the Healthcare sector (Medical Devices).
The current price is 13.65 with a P/E ratio of -x and P/B of -x.
ROE is -2.07% and operating margin is -1.91%. Annual revenue is $3.8B.